List of Selected Publications

1. Fujii S, Motohashi S, Shimizu K, Nakayama T, Yoshiga Y, and Taniguchi M
   "Aduvant activity mediated by iNKT cells"
   Semin Immunol, 22, 97-102 (2010)
2. Fujii S, Takayama T, Asakura M, Aki K, Fujimoto K, and Shimizu K.
   "Dendritic cell-based cancer immunotherapies."
   Arch Immunol Ther Exp., 57, 189-198 (2009)
3. Fujii S, Goto A, and Shimizu K.
   "Antigen mRNA-transfected, allogeneic fibroblasts loaded with NKT cell ligand confer antitumor immunity"
   Blood, 113, 4262-4272 (2009)
4. Shimizu K, and Fujii S.
   "DC therapy induces long-term NK reactivity to tumors via host DC"
   Eur J. Immunol., 39, 457-468 (2009)
5. Shimizu K, and Fujii S.
   "An adjuvant role of in situ dendritic cells (DCs) in linking innate and adaptive immunity."
   Front in Bioscience., 13, 6193-6201 (2008)
6. Fujii S.
   "Exploiting dendritic cells (DCs) and NKT cells in immunotherapy against malignancies."
   Trends Immunol., 29, 242-249 (2007)
7. Fujii S, Shimizu K, Hemmi H, and Steinman RM.
   "Innate Va14+natural killer T cells mature dendritic cells, leading to strong adaptive immunity."
   Immunological Rev., 220, 183-198 (2007)
8. Shimizu K, Kurosawa Y, Taniguchi M, Steinman RM, and Fujii S.
   "Cross-presentation of glycolipid from tumor cells loaded with alpha-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells."
   J Exp Med., 204, 2641-2653 (2007).
9. Shimizu K, Goto A, Fukui M, Taniguchi M, and Fujii S.
   "Tumor cells loaded with a-GalCer induce innate NKT and NK cell-dependent resistance-tumor implantation in mice."
   J Immunol., 178, 2853-2861 (2007).
10. Shimizu K., Hidaka M, Kadowaki N, Makita N, Konishi N, Fujimoto K., Uchiyama T, Kawano F, Taniguchi M, and Fujii S.
    "Evaluation of the function of human invariant NKT cells from cancer patients using a-GalCer-loaded murine dendritic cells."
    J Immunol., 177, 3484-3492 (2006).

Members